Inhibrx Announces Participation in Upcoming Investor Conference

Rhea-AI Summary

Inhibrx, Inc. (Nasdaq: INBX) announced its participation in the 5th Annual HealthCONx Conference on November 30 at 8:45 a.m. PT. This virtual investor conference will include a live webcast of the presentation, available for at least 60 days on Inhibrx's investor website.

As a clinical-stage biopharmaceutical company, Inhibrx focuses on therapeutics for oncology and rare diseases, employing innovative protein engineering techniques. To learn more, visit www.inhibrx.com.

SAN DIEGO, Nov. 18, 2022 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at the following upcoming virtual investor conference:

The Evercore ISI 5th Annual HealthCONx Conference
Wednesday, November 30^th at 8:45 a.m. Pacific Time

The investor conference presentation will be webcast live for at least 60 days following the event and will be accessible through a link on the investors section of Inhibrx's website at https://inhibrx.investorroom.com/events-and-presentations.

About Inhibrx, Inc.

Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with 2seventy bio (formerly bluebird bio), Bristol-Myers Squibb and Chiesi. For more information, please visit www.inhibrx.com.

Investor and Media Contact:

Kelly Deck
CFO
kelly@inhibrx.com
858-795-4260

View original content to download multimedia:https://www.prnewswire.com/news-releases/inhibrx-announces-participation-in-upcoming-investor-conference-301682619.html

SOURCE Inhibrx Inc.

FAQ

What conference will Inhibrx present at on November 30, 2022?

Inhibrx will present at the 5th Annual HealthCONx Conference on November 30, 2022.

What time is Inhibrx's presentation at the HealthCONx Conference?

Inhibrx's presentation is scheduled for 8:45 a.m. Pacific Time on November 30, 2022.

How long will the Inhibrx conference presentation be available for viewing?

The presentation will be webcast live and accessible for at least 60 days following the event.

Where can I find more information about Inhibrx?

More information about Inhibrx can be found on their website at www.inhibrx.com.